Quoin grants exclusive license for QRX003 in Singapore to Farma Mondo

Quoin Pharmaceuticals, Ltd.

Exclusive license to Farma Mondo SA to commercialize QRX003 in Singapore.
Licensee must file for regulatory approvals within 6 months of Quoin's FDA/EMA approval.
Financial terms not disclosed; royalties payable to Quoin.
Parties to negotiate supply agreement for product manufacture and supply.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Quoin Pharmaceuticals, Ltd. entered into Exclusive License and Distribution Agreement with Farma Mondo SA valued at Exclusive license to commercialize QRX003 in Singapore, royalty-bearing (effective 2023-09-01).

Action: entry
Agreement: license
Counterparty: Farma Mondo SA
Value: Exclusive license to commercialize QRX003 in Singapore, royalty-bearing
Effective: 2023-09-01

Exact text from the filing

On September 6, 2023, Quoin Pharmaceuticals Ltd. (the “Company”) entered into an Exclusive License and Distribution Agreement, effective as of September 1, 2023 (the “License Agreement”), with Farma Mondo SA, a company incorporated under the laws of Switzerland (“Farma Mondo”). Pursuant to the License Agreement, the Company granted to Farma Mondo an exclusive license under its Product Technology (as defined in the License Agreement) to commercialize, upon receipt of applicable regulatory approvals, pharmaceutical product QRX003 (in finished dosage form for human use) in Singapore.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Quoin Pharmaceuticals, Ltd. filing history →

Source: SEC EDGAR

accession 0001104659-23-100115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.